-->
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID-19 Impact on Egg Freezing and Embryo Banking Market
5.1. COVID-19 Landscape: Egg Freezing and Embryo Banking Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Egg Freezing and Embryo Banking Market, By Type
8.1. Egg Freezing and Embryo Banking Market, by Type, 2025-2033
8.1.1 Donor
8.1.1.1. Market Revenue and Forecast (2024-2033)
8.1.2. Non-donor
8.1.2.1. Market Revenue and Forecast (2024-2033)
Chapter 9. Global Egg Freezing and Embryo Banking Market, By Preservation
9.1. Egg Freezing and Embryo Banking Market, by Preservation, 2025-2033
9.1.1. Egg Freezing
9.1.1.1. Market Revenue and Forecast (2024-2033)
9.1.2. Embryo Freezing
9.1.2.1. Market Revenue and Forecast (2024-2033)
Chapter 10. Global Egg Freezing and Embryo Banking Market, By Age of Patient
10.1. Egg Freezing and Embryo Banking Market, by Age of Patient, 2025-2033
10.1.1. Under 35
10.1.1.1. Market Revenue and Forecast (2024-2033)
10.1.2. 35-37
10.1.2.1. Market Revenue and Forecast (2024-2033)
10.1.3. 38-40
10.1.3.1. Market Revenue and Forecast (2024-2033)
10.1.4. Over 42
10.1.4.1. Market Revenue and Forecast (2024-2033)
Chapter 11. Global Egg Freezing and Embryo Banking Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.1.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.1.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.1.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.1.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.2.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.2.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.2.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.6.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.2.6.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.2.7.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.2.7.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.3.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.3.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.3.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.6.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.3.6.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.3.7.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.3.7.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.4.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.4.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.6.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.4.6.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2024-2033)
11.4.7.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.4.7.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.4.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.5.4.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2024-2033)
11.5.5.2. Market Revenue and Forecast, by Preservation (2024-2033)
11.5.5.3. Market Revenue and Forecast, by Age of Patient (2024-2033)
Chapter 12. Company Profiles
12.1. ReproTech LLC
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cryos International
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. CCRM Fertility
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. RMA Network
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Carrot Fertility
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. WINFertility
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Columbia University
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Shady Grove Fertility
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Kindbody
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます